Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04304001 · ClinicalTrials.gov registry record · NA

Test Up Now Education Program

A NA study of Colorectal Cancer Screening, sponsored by Florida A&M University.

Completed
Registry status
NA
Development phase
115
Enrollment target
1
Study location

NCT04304001: Completed NA study of Colorectal Cancer Screening, sponsored by Florida A&M University.

NCT04304001 is a NA study of Colorectal Cancer Screening that has completed, run by Florida A&M University. The registered enrollment target is 115 participants, below the 5,877-participant average among 19 other Colorectal Cancer Screening trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04304001, a NA study of Colorectal Cancer Screening, has completed, sponsored by Florida A&M University.

COMPLETED
Registry status
NA
Development phase
115 participants
Enrollment target
1
Study location

Study Summary

This study will test the effectiveness of an outreach strategy to increase colorectal cancer screening in African Americans. The investigators will recruit 250 African Americans ages 45-64 years who are not up-to-date with colorectal cancer screening or have never been screened, with the goal to evaluate screening knowledge, behavior, and intervention effects on colorectal cancer screening outcomes. Participants will be randomly assigned to the TUNE-UP intervention or a control group. The TUNE-UP intervention arm will utilize a community health advisor to encourage return of stool blood testing kits through cell phone outreach. The control group will receive educational materials about colorectal cancer screening plus a resource list but no community health advisor counseling support or cellphone / text contact. The primary study outcome is receipt of colorectal cancer screening (colonoscopy or Fecal Immunochemical Test) following the intervention. The secondary outcomes will include colorectal cancer screening knowledge, self-efficacy (confidence to receive colorectal cancer screening), intention to screen, and follow-up in the case of an abnormal test result. The research objective is to test the community health advisor intervention effectiveness for promoting stool blood testing as a preferred screening test in an under-screened African American population.

Primary Outcome

The colorectal cancer screening measure asks about completion of colonoscopy and blood stool tests. These tests are described prior to questions about completion of each test. The first question asks when was the most recent stool blood test (\> 1 year but \< 2 years ago; \> 2 years but not more than 5 years ago; or \> 5 years). The second question asks when was the most recent colonoscopy (a year ago or less; \> 1 year but \< 5 years ago; \> 5 years but not more than 10 years ago; or \> 10 year

Interventions

  • BEHAVIORAL Usual care
  • BEHAVIORAL Community Health Advisor

Study Locations (1)

Florida

  • Florida A&M University - Tallahassee

Trial Details

FieldValue
Enrollment Target 115 participants
Start Date 2021-04-07
Est. Completion 2024-02-12
Phase NA
Florida A&M University

3 total trials

What the finished NCT04304001 record still lists

NCT04304001 is an interventional study that assigns participants to a tested intervention. The registered 115 participants enrollment target is mid-sized for trials with a published cap, below the 5,877-participant average among 19 other Colorectal Cancer Screening trials with a reported enrollment target (98% lower).

The record links to 1 condition, with Colorectal Cancer Screening appearing as the primary indexed condition, and to 2 interventions - of which Usual care is the first listed.

NCT04304001 reports a single indexed study location in Florida.

Frequently Asked Questions

What is clinical trial NCT04304001 about?

NCT04304001 is a clinical study titled "Test Up Now Education Program". This study will test the effectiveness of an outreach strategy to increase colorectal cancer screening in African Americans. The investigators will recruit 250 African Americans ages 45-64 years who are not up-to-date with colorectal cancer screening or have never been screened, with the goal to eva...

What is the current status of trial NCT04304001?

This trial is currently completed. It is a NA study. The enrollment target is 115 participants. The study started on 2021-04-07. Estimated completion is 2024-02-12.

What conditions does trial NCT04304001 study?

This clinical trial studies the following conditions: Colorectal Cancer Screening.

What interventions are being tested in trial NCT04304001?

The interventions under investigation include: Usual care (BEHAVIORAL), Community Health Advisor (BEHAVIORAL).

Who is sponsoring clinical trial NCT04304001?

This trial is sponsored by Florida A&M University, which has 3 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04304001 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Colorectal Cancer Screening

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04304001's enrollment target sits among peer trials

115 14th of 19 higher than 6 of 19 other Colorectal Cancer Screening trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Colorectal Cancer Screening trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02346929 · 115 participants · NA

    Hematoma Block for Distal Radius Fracture

  • NCT03394365 · 115 participants · Phase 3

    A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure With Rituximab or Rituximab and Chemotherapy

  • NCT03907475 · 115 participants · Phase 2

    Durvalumab in Combination With Chemotherapy in Treating Patients With Advanced Solid Tumors, DURVA+ Trial

  • NCT05086692 · 115 participants · Phase 1

    A Beta-only IL-2 ImmunoTherapY Study

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04304001, the US trial registry maintained by the National Library of Medicine. NCT04304001 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.